Unlock stock picks and a broker-level newsfeed that powers Wall Street.
4.4000
-0.2400
(-5.17%)
At close: April 4 at 8:00:35 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | 23.03M | 23.2M | 88.67M | 96.15M |
| Low Estimate | 22.3M | 22.9M | 87.6M | 93.3M |
| High Estimate | 24.4M | 23.6M | 90.2M | 99M |
| Year Ago Sales | 23.02M | 21.23M | 85.88M | 88.67M |
| Sales Growth (year/est) | 0.04% | 9.29% | 3.25% | 8.44% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EP7.F | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Maintains | Northland Capital Markets: Outperform to Outperform | 2/6/2025 |
| Maintains | Roth MKM: Buy to Buy | 4/4/2024 |
| Reiterates | Roth MKM: Buy to Buy | 9/18/2023 |
| Upgrade | Roth Capital: Neutral to Buy | 11/10/2022 |
| Initiated | Northland Capital Markets: Outperform | 7/12/2022 |
| Downgrade | Roth Capital: Buy to Neutral | 7/6/2022 |